D. Nathan Kim
Papers
1
Total Citations
23
H-Index
1
About
D. Nathan Kim is a leading radiation oncologist whose research focuses on advancing stereotactic body radiation therapy (SBRT) for breast cancer, particularly through innovative partial breast irradiation techniques. His most cited work, a 2021 multi-institutional phase 1 dose escalation trial, pioneered single-fraction stereotactic partial breast irradiation (S-PBI) for early-stage breast cancer using a robotic stereotactic system. This study, with 23 citations, demonstrated the feasibility and safety of delivering precise, high-dose radiation in a single session after partial mastectomy—a significant departure from conventional multi-week regimens. Kim’s contributions are reshaping breast cancer treatment by reducing treatment burden while maintaining efficacy, with his findings informing ongoing clinical protocols. His work exemplifies the integration of advanced radiation technology into personalized cancer care, offering patients shorter, less invasive options. As a key figure in this evolving field, Kim’s research continues to influence radiation oncology practice, with his phase 1 results laying groundwork for larger trials aimed at establishing S-PBI as a standard option for select early-stage breast cancer patients.
Research Focus
Key Achievements
Top Papers
- 1